Patents by Inventor Thomas Sciascia

Thomas Sciascia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF PRURIGO NODULARIS
    Publication number: 20230338367
    Abstract: The present invention relates to methods for treating prurigo nodularis with anti-pruritic compositions, wherein the method provides a therapeutic effect in a patient.
    Type: Application
    Filed: June 27, 2023
    Publication date: October 26, 2023
    Inventors: Thomas SCIASCIA, Jennifer L. GOOD, Amale HAWI
  • Treatment of chronic cough, breathlessness and dyspnea
    Patent number: 11660296
    Abstract: The present invention relates to methods for treating patients with chronic cough with nalbuphine compositions as well as treating cough, breathlessness, or dyspnea associated with IPF with nalbuphine compositions, wherein the method provides a therapeutic effect in a patient.
    Type: Grant
    Filed: March 24, 2022
    Date of Patent: May 30, 2023
    Assignee: Trevi Therapeutics, Inc.
    Inventor: Thomas Sciascia
  • TREATMENT OF CHRONIC COUGH, BREATHLESSNESS AND DYSPNEA
    Publication number: 20220409613
    Abstract: The present invention relates to methods for treating patients with chronic cough with nalbuphine compositions as well as treating cough, breathlessness, or dyspnea associated with IPF with nalbuphine compositions, wherein the method provides a therapeutic effect in a patient.
    Type: Application
    Filed: January 14, 2022
    Publication date: December 29, 2022
    Inventor: Thomas SCIASCIA
  • TREATMENT OF PRURIGO NODULARIS
    Publication number: 20220347171
    Abstract: The present invention relates to methods for treating prurigo nodularis with anti-pruritic compositions, wherein the method provides a therapeutic effect in a patient.
    Type: Application
    Filed: December 8, 2021
    Publication date: November 3, 2022
    Inventors: Thomas Sciascia, Jennifer L. Good, Amale Hawi
  • METHODS OF ADMINISTERING NALBUPHINE
    Publication number: 20220265640
    Abstract: Provided herein are methods of treating nalbuphine-treatable disorders in a hepatically impaired patient.
    Type: Application
    Filed: May 9, 2022
    Publication date: August 25, 2022
    Inventors: Thomas SCIASCIA, Shashank ROHATAGI
  • TREATMENT OF CHRONIC COUGH, BREATHLESSNESS AND DYSPNEA
    Publication number: 20220218697
    Abstract: The present invention relates to methods for treating patients with chronic cough with nalbuphine compositions as well as treating cough, breathlessness, or dyspnea associated with IPF with nalbuphine compositions, wherein the method provides a therapeutic effect in a patient.
    Type: Application
    Filed: March 24, 2022
    Publication date: July 14, 2022
    Inventor: Thomas SCIASCIA
  • TREATMENT OF CHRONIC COUGH, BREATHLESSNESS AND DYSPNEA
    Publication number: 20200022974
    Abstract: The present invention relates to methods for treating patients with chronic cough with nalbuphine compositions as well as treating cough, breathlessness, or dyspnea associated with IPF with nalbuphine compositions, wherein the method provides a therapeutic effect in a patient.
    Type: Application
    Filed: July 23, 2019
    Publication date: January 23, 2020
    Inventor: Thomas Sciascia
  • TREATMENT OF THE PRURITIC SYMPTOMS OF LIVER DISEASE
    Publication number: 20200016150
    Abstract: The present disclosure relates to methods for treating patients with pruritus associated with liver disease with anti-pruritic compositions; methods for treating patients with pruritus associated with obstructive cholestasis secondary to bile duct obstruction due to non-hepatic tissue disease; and the anti-pruritic compositions used in such methods.
    Type: Application
    Filed: July 10, 2019
    Publication date: January 16, 2020
    Inventors: Thomas Sciascia, Amale Hawi
  • Sustained release formulations of nalbuphine
    Patent number: 10406106
    Abstract: Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided.
    Type: Grant
    Filed: November 21, 2018
    Date of Patent: September 10, 2019
    Assignee: ENDO PHARMACEUTICALS INC.
    Inventors: Anand R. Baichwal, Philip A. Goliber, Anthony E. Carpanzano, Thomas Sciascia, Donald Diehl, Brian Vogler, David Verbel, Stanley Au
  • SUSTAINED RELEASE FORMULATIONS OF NALBUPHINE
    Publication number: 20190117576
    Abstract: Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided.
    Type: Application
    Filed: November 21, 2018
    Publication date: April 25, 2019
    Inventors: Anand R. BAICHWAL, Philip A. GOLIBER, Anthony E. CARPANZANO, Thomas SCIASCIA, Donald DIEHL, Brian VOGLER, David VERBEL, Stanley AU
  • METHODS FOR TREATING PRURITUS
    Publication number: 20190099416
    Abstract: The present invention relates to methods for treating pruritus with anti-pruritic compositions.
    Type: Application
    Filed: April 30, 2018
    Publication date: April 4, 2019
    Inventor: Thomas Sciascia
  • Methods for treating pruritus
    Patent number: 10238646
    Abstract: The present invention relates to methods for treating pruritus with anti-pruritic compositions.
    Type: Grant
    Filed: December 30, 2015
    Date of Patent: March 26, 2019
    Assignee: Trevi Therapeutics Inc.
    Inventor: Thomas Sciascia
  • Sustained release formulation of nalbuphine
    Patent number: 10172798
    Abstract: Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided.
    Type: Grant
    Filed: July 24, 2017
    Date of Patent: January 8, 2019
    Assignee: Endo Pharmaceuticals Inc.
    Inventors: Anand R. Baichwal, Philip A. Goliber, Anthony E. Carpanzano, Thomas Sciascia, Donald Diehl, Brian Vogler, David Verbel, Stanley Au
  • TREATMENT OF PRURIGO NODULARIS
    Publication number: 20180125840
    Abstract: The present invention relates to methods for treating prurigo nodularis with anti-pruritic compositions, wherein the method provides a therapeutic effect in a patient.
    Type: Application
    Filed: October 25, 2017
    Publication date: May 10, 2018
    Inventors: Thomas Sciascia, Jennifer L. Good, Amale Hawi
  • SUSTAINED RELEASE FORMULATION OF NALBUPHINE
    Publication number: 20180042852
    Abstract: Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided.
    Type: Application
    Filed: July 24, 2017
    Publication date: February 15, 2018
    Inventors: Anand R. BAICHWAL, Philip A. GOLIBER, Anthony E. CARPANZANO, Thomas SCIASCIA, Donald DIEHL, II, Brian VOGLER, David VERBEL, Stanley AU
  • TREATMENT OF UREMIC PRURITUS
    Publication number: 20180008592
    Abstract: The present invention relates to methods for treating uremic pruritus with anti-pruritic compositions, wherein the method provides a therapeutic effect in a patient.
    Type: Application
    Filed: March 21, 2017
    Publication date: January 11, 2018
    Inventors: Thomas Sciascia, Jennifer L. Good, Amale Hawi
  • THERAPEUTIC USE OF NALBUPHINE WITHOUT AQUARETIC EFFECTS
    Publication number: 20170216277
    Abstract: The present invention relates to methods for treating pruritus with anti-pruritic compositions, wherein the method provides a therapeutic effect without producing a substantial aquaretic effect.
    Type: Application
    Filed: January 6, 2017
    Publication date: August 3, 2017
    Inventor: THOMAS SCIASCIA
  • METHODS FOR TREATING PRURITUS
    Publication number: 20170000782
    Abstract: The present invention relates to methods for treating uremic pruritus with anti-pruritic compositions.
    Type: Application
    Filed: February 5, 2016
    Publication date: January 5, 2017
    Inventor: Thomas SCIASCIA
  • METHODS FOR TREATING PRURITUS
    Publication number: 20160346273
    Abstract: The present invention relates to methods for treating pruritus with anti-pruritic compositions.
    Type: Application
    Filed: December 30, 2015
    Publication date: December 1, 2016
    Inventor: Thomas Sciascia
  • SUSTAINED RELEASE FORMULATION OF NALBUPHINE
    Publication number: 20160263035
    Abstract: Sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; methods for making the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof; and methods for using the sustained release formulations of nalbuphine or pharmaceutically acceptable salts thereof to treat patients suffering from pain are provided.
    Type: Application
    Filed: May 23, 2016
    Publication date: September 15, 2016
    Applicant: Endo Pharmaceuticals Inc.
    Inventors: Anand R. BAICHWAL, Philip A. Goliber, Anthony E. Carpanzano, Thomas Sciascia, Donald Diehl, Brian Vogler, David Verbel, Stanley Au